Elevated Plasma Pentraxin 3 Levels Are Associated With Development and Progression of Diabetic Retinopathy in Korean Patients With Type 2 Diabetes Mellitus
Elevated Plasma Pentraxin 3 Levels Are Associated With Development and Progression of Diabetic Retinopathy in Korean Patients With Type 2 Diabetes Mellitus
复制标题
DOI:
10.1167/iovs.14-14864
复制
发表时间:
2014-09-01
影响因子:
4.4
通讯作者:
Woo, Je Moon
中科院分区:
文献类型:
--
作者:
Yang, Hyun Seung;Woo, Jong Eun;Woo, Je Moon
PURPOSE. To evaluate the association between elevated levels of plasma pentraxin 3 (PTX3) and the development and/or progression of diabetic retinopathy (DR).METHODS. In this case-control study, 92 diabetic patients with DR (group 3), 30 diabetic patients without DR (group 2), and 41 normal subjects (group 1) were enrolled. Log transformed values of plasma PTX3 and high-sensitivity C-reactive protein (hsCRP) concentrations were measured and used in our analysis. For subgroup analysis, group 3 was divided into four subgroups: mild, moderate, severe nonproliferative, and proliferative DR.RESULTS. In our 163 participants, average plasma PTX3 levels were 916.1 +/- 532.2, 1093.7 +/- 1034.2, and 1817.9 +/- 1776.9 pg/mL for groups 1, 2, and 3, respectively. The duration of diabetic mellitus (DM), glycated hemoglobin (HbA1c), log hsCRP, and log PTX3 were significantly different between the three groups (P = 0.008, P < 0.001, P = 0.046, and P < 0.001, respectively). In subgroup analysis, plasma log PTX3 levels increased in correlation with the severity of DR (R = 0.372, P < 0.001). Multivariate logistic analysis showed that the correlation between DR development and duration of DM and log PTX3 values was significant (P = 0.014 and P = 0.025, respectively), whereas correlation with log hsCRP values was not significant in univariate analysis (P = 0.129). The receiver operating characteristic curves of DR development were plotted using log PTX3 and log hsCRP values, and the area under the curves was found to be 0.721 (P = 0.001) and 0.614 (P = 0.087), respectively.CONCLUSIONS. Plasma PTX3 is positively associated with DR development and progression, and may be a more accurate predictor of DR development than hsCRP.